This study evaluated budesonide formoterol efficacy and safety of a novel asthma management strategy for both maintenance and symptom relief (Symbicort Single Inhaler Therapy) – compared with a higher maintenance dose of budesonide in patients with moderate to severe asthma. (more…)
Asthma control is improved by combining inhaled corticosteroids with long acting beta-agonists but patients still require relie ...
This study was similar to the study of Harrison and colleagues, which looked at doubling the dose of inhaled corticosteroid dur ...
Regular use of ß-agonists has been known to lead to tolerance to their bronchodilator effects. It is not known how quickly toleranc ...
Two long-acting ß 2 -adrenergic agonists (LABAs), salmeterol and formoterol, have been demonstrated to be safe and effective ag ...
The guidelines for asthma management recommend the use of regular inhaled corticosteroid in patients with mild persistent asthma, b ...
Atopy can be determined as such the production of specific IgE response to common exposure to environmental allergens like dust mites, grass and cat or pets. Living with atopic allergic diseases such as asthma, allergic rhinitis linked, and eczema, but not everyone with atopy develops clinical manifestations of allergy and not everyone can be detected in clinical allergy syndrome, atopic diseases, it has been tested for specific IgE for a wide range of environmental allergens. This is especially true for asthma. (more…)
About twenty percent of patients who have common allergic rhinitis are also having perennial allergic rhinitis symptoms. This f ...
If someone has allergies, and it is particularly food allergies, does it change his or her quality of life? The effects of a ...
Specific immunotherapy has been widely used to treat allergic rhinitis symptoms. As with any other form of specific immunotherapy, ...
Treatment of allergic diseases in childhood presents unique challenges, as both the beneficial effects and the detrimenta ...
In 2004, there were 2.4 million children aged 5 to 14 years, or 5.9% of this population group, with a self-reported asthma atta ...
Avoidance of respiratory irritants such as environmental tobacco smoke, whether actively or passively inhaled, is universally recommended and is considered to be fundamentally important in the successful treatment of asthma and allergic rhinitis. Control of environmental airborne allergens such as house dust mites for prevention of asthma, allergic rhinitis, or atopic dermatitis/What Does Eczema Look Like is also widely recommended, although not supported by all studies. (more…)
First-generation, relatively sedating oral H1 antihistamines such as diphenhydramine and chlorpheniramine have no role in the out-o ...
There is nothing more scary for a new parent than the thought that their child might get sick. But while most parents manage to ...
Children in the early of their life is prone to allergy because their body immune system is not developed completely. As a matter o ...
About ninety percent of Americans spend most of their time indoors, not knowing that the air inside your home can contain potential ...
Do you suffer from allergies and asthma? If yes, then probably you are very sensitive to allergens and particles suspended in the a ...
Roflumilast is an oral, once-daily PDE4 inhibitor with antiinflammatory activity in development for the treatment of asthma. Roflumilast was compared with inhaled beclomethasone dipropionate in patients with asthma.
Once-daily, oral roflumilast 500 µg was comparable with inhaled twice-daily beclomethasone dipropionate (400 µg/day) in improving pulmonary function and asthma symptoms, and reducing the use of rescue medication in patients with asthma. (more…)
Treating allergic rhinitis may have a downstream effect on concomitant asthma and this may be due to attenuation of the underlying ...
Roflumilast is an oral, once-daily inhibitor of phosphodiesterase type 4 (PDE4) that prevents the breakdown of cyclic adenosine ...
Despite optimum drug delivery and good compliance with inhaled corticosteroids, many patients experience symptoms and exacerbat ...
The guidelines for asthma management recommend the use of regular inhaled corticosteroid in patients with mild persistent asthma, b ...
For most patients, asthma is not controlled as defined by guidelines; whether this is achievable has not been prospectively stu ...